Related Experiment Video
Updated: Jul 11, 2026

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Heart transplantation for Churg-Strauss syndrome
D Thomson1, H Chamsi-Pasha, P Hasleton
1Department of Cardiothoracic Surgery, Wythenshawe Hospital, Manchester.
British Heart Journal
|November 1, 1989
Summary
Heart failure from Churg-Strauss syndrome was successfully treated with a heart transplant. This case is notable for minimal lung involvement, with the patient maintaining good health post-transplant on standard immunotherapy.
Area of Science:
- Cardiology
- Pulmonology
- Immunology
Background:
- Churg-Strauss syndrome, also known as eosinophilic granulomatosis with polyangiitis, is a rare autoimmune disorder.
- It typically affects the respiratory system and can lead to severe cardiac complications, including heart failure.
- Cardiac involvement in Churg-Strauss syndrome often presents with eosinophilic myocarditis.
Observation:
- A patient presented with heart failure attributed to Churg-Strauss syndrome.
- Diagnostic evaluation revealed minimal evidence of pulmonary involvement, which is atypical for this condition.
- The patient's heart failure necessitated a heart transplant for management.
Findings:
- Successful heart transplantation was performed for heart failure secondary to Churg-Strauss syndrome.
- The absence of significant lung disease in this case presented an unusual clinical manifestation.
- The patient's post-transplant recovery was favorable under standard immunosuppressive therapy.
Implications:
- This case highlights the potential for cardiac-dominant Churg-Strauss syndrome, even with subtle pulmonary findings.
- Heart transplantation can be a viable treatment option for end-stage heart failure caused by this syndrome.
- Long-term management with standard transplant immunotherapy appears effective in preventing recurrence or rejection.

